Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Fountain Pharmaceuticals

This article was originally published in The Tan Sheet

Executive Summary

Fountain Pharmaceuticals: Has entered into a long-term licensing and supply agreement with Dermik Labs for products using Fountain's encapsulation delivery system, the company announced Jan. 19. Collegetown, Penn.-based Dermik, a subsidiary of Rhone-Poulenc Rorer, currently markets Hytone hydrocortisone cream, Zetar coal tar shampoo, and Shepard's cream lotion, while Fountain is mostly involved in moisturizers and sunscreens. The companies plan to begin introducing new products domestically and internationally within the next few months under the agreement...
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS084682

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel